Newbridge Financial Services Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Newbridge Financial Services Group’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,350	Closed	-$5.9K	–	1472
2023 Q1	$5.9K	Sell	13,350 -7,000	-34%	-$2.74K	﹤0.01%	1025
2022 Q4	$4.47K	Hold	20,350	–	–	﹤0.01%	1087
2022 Q3	$7K	Hold	20,350	–	–	﹤0.01%	990
2022 Q2	$13K	Hold	20,350	–	–	0.01%	797
2022 Q1	$17K	Sell	20,350 -14,725	-42%	-$13.7K	0.01%	780
2021 Q4	$40K	Sell	35,075 -26,600	-43%	-$54.2K	0.02%	531
2021 Q3	$154K	Sell	61,675 -12,825	-17%	-$35.6K	0.1%	206
2021 Q2	$221K	Sell	74,500 -12,685	-15%	-$44.2K	0.14%	166
2021 Q1	$306K	Buy	87,185 +13,685	+19%	+$76.2K	0.23%	109
2020 Q4	$349K	Buy	+73,500	New	+$380K	0.29%	81

Other funds holding CEMI

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Newbridge Financial Services Group's CEMI Position: Q2 2023 in Review

Newbridge Financial Services Group sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 13,350 shares — an estimated $5.9K sold.

Newbridge Financial Services Group first reported a position in CEMI in Q4 2020 and held it in 10 quarters. The position peaked at $349K in Q4 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

Newbridge Financial Services Group reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
Newbridge Financial Services Group sold 13,350 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $5.9K.
Newbridge Financial Services Group first reported a position in Chembio diagnostics, Inc. in Q4 2020 and held it in 10 quarters.
Newbridge Financial Services Group's Chembio diagnostics, Inc. position peaked at $349K in Q4 2020.
1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Newbridge Financial Services Group's 13F filing for Q2 2023, filed 21 Jul 2023.